Let's Talk Cough

The Asthma and Allergy Foundation of America (AAFA), COPD Foundation, Global Allergy & Airways Patient Platform (GAAPP), and the Pulmonary Fibrosis Foundation (PFF) announce the Let’s Talk Cough initiative, a groundbreaking joint effort to highlight the lived experience of chronic cough. This initiative aims to fully describe the impact of chronic cough on the lives of those affected across many conditions, their current management strategies, unmet medical needs, and treatment benefits that matter most to them, to inform the development of new therapies.

On October 28, 2026, the Let’s Talk Cough initiative will culminate in a hybrid, externally-led patient-focused drug development (EL-PFDD) meeting, conducted in parallel with the U.S. Food and Drug Administration’s (FDA) PFDD initiative. The meeting will be streamed live, bringing members of the global chronic cough community together to share their experiences and perspectives. A “Voice of the Patient” report will summarize insights gathered during the Let’s Talk Cough meeting and throughout the planning process, creating an invaluable resource for researchers, life science companies, regulators, healthcare professionals, members of the chronic cough community, and others.

Visit letstalkcough.org and complete the sign-up form to receive timely updates about the meeting on October 28, 2026 and other opportunities to participate and spread the word.